Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ReNerve.
RELATED STOCKHEAD STORIES
Health & Biotech
ReNerve inks deal to expand nerve-repair product in Hong Kong and Macau
Health & Biotech
Health Check: No sign of frayed nerves as Orthocell girds for US approval
Health & Biotech
Scott Power: Which ASX healthcare stock has soared 30pc this week?
Stockhead TV
Long Shortz with ReNerve: Welcome to the ASX
Health & Biotech
Health Check: Biotech double-banger breaks the IPO drought
Health & Biotech